Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594174 | SCV000708244 | benign | not specified | 2017-05-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000871340 | SCV001012977 | benign | Duchenne muscular dystrophy | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001534368 | SCV001751292 | benign | not provided | 2020-06-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448837 | SCV002682069 | benign | Cardiovascular phenotype | 2020-06-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002498864 | SCV002811910 | benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2021-08-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829678 | SCV002080215 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2021-07-06 | no assertion criteria provided | clinical testing |